Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels
Platelet activation plays a key role in cardiovascular diseases. The generation of mitochondrial reactive oxygen species (ROS) has been described as a critical step required for platelet activation. For this reason, it is necessary to find new molecules with antiplatelet activity and identify their...
Main Authors: | Diego Méndez, Diego Arauna, Francisco Fuentes, Ramiro Araya-Maturana, Iván Palomo, Marcelo Alarcón, David Sebastián, Antonio Zorzano, Eduardo Fuentes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6192 |
Similar Items
-
Does Antioxidant Mitoquinone (MitoQ) Ameliorate Oxidative Stress in Frozen–Thawed Rooster Sperm?
by: Lingwei Sun, et al.
Published: (2022-11-01) -
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases
by: Lateef Adegboyega Sulaimon, et al.
Published: (2022-07-01) -
The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
by: Fabrizio Pin, et al.
Published: (2022-03-01) -
MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice
by: Tania Capeloa, et al.
Published: (2022-03-01) -
Therapeutic effects of the combination of moderate-intensity endurance training and MitoQ supplementation in rats with isoproterenol-induced myocardial injury: The role of mitochondrial fusion, fission, and mitophagy
by: Farzaneh Rostamzadeh, et al.
Published: (2024-01-01)